IRIS
ZANARDI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.814
AS - Asia 872
NA - Nord America 661
Continente sconosciuto - Info sul continente non disponibili 203
SA - Sud America 89
AF - Africa 12
Totale 8.651
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.653
US - Stati Uniti d'America 612
SG - Singapore 353
CN - Cina 210
VN - Vietnam 151
BD - Bangladesh 93
BR - Brasile 59
FR - Francia 56
FI - Finlandia 28
HK - Hong Kong 20
CA - Canada 18
GB - Regno Unito 14
DE - Germania 13
AR - Argentina 11
JP - Giappone 11
MX - Messico 8
ES - Italia 7
IN - India 6
JM - Giamaica 6
CH - Svizzera 5
ID - Indonesia 5
IE - Irlanda 5
IQ - Iraq 5
PE - Perù 5
CO - Colombia 4
HN - Honduras 4
NL - Olanda 4
PK - Pakistan 4
RO - Romania 4
RU - Federazione Russa 4
AL - Albania 3
CL - Cile 3
JO - Giordania 3
NI - Nicaragua 3
SV - El Salvador 3
UA - Ucraina 3
ZA - Sudafrica 3
BE - Belgio 2
CR - Costa Rica 2
ET - Etiopia 2
GR - Grecia 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
SI - Slovenia 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AT - Austria 1
BB - Barbados 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
GT - Guatemala 1
HR - Croazia 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
RE - Reunion 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.449
Salva come PNG Salva come JPEG
Città #
Genova 3.352
Genoa 2.024
Rapallo 682
Vado Ligure 535
Singapore 185
San Jose 137
Ashburn 63
Lauterbourg 50
Ho Chi Minh City 43
Beijing 42
Hanoi 35
New York 34
Council Bluffs 30
Helsinki 28
Hong Kong 18
Santa Clara 16
Los Angeles 14
Chicago 10
Frankfurt am Main 10
Bordighera 8
Tokyo 8
Atlanta 6
Buffalo 6
Haiphong 6
Mexico City 6
Orem 6
São Paulo 6
Biên Hòa 5
Brooklyn 5
Dallas 5
Kingston 5
Milan 5
Newark 5
Zurich 5
Dublin 4
Guangzhou 4
Madrid 4
Montreal 4
Rome 4
San Antonio 4
Amman 3
Amsterdam 3
City of London 3
Jakarta 3
Managua 3
Miami 3
Mumbai 3
Nuremberg 3
Philadelphia 3
Phoenix 3
Rockford 3
San Salvador 3
Santiago 3
The Bronx 3
Thái Nguyên 3
Tianjin 3
Tirana 3
Toronto 3
Addis Ababa 2
Agawam 2
Anderson 2
Anna 2
Arroyo Grande 2
Azusa 2
Boardman 2
Bridgeport 2
Bắc Ninh 2
Campagnano di Roma 2
Can Tho 2
Cardiff 2
Charlotte 2
Cleveland 2
Da Nang 2
Denver 2
Ely 2
Fresno 2
Hinesville 2
Hoover 2
Houston 2
Indpls 2
Karachi 2
Lisbon 2
Ljubljana 2
London 2
Marietta 2
Martin 2
Montevideo 2
Nantong 2
Naples 2
Ninh Bình 2
North Las Vegas 2
Orangeburg 2
Palermo 2
Parker 2
Phủ Lý 2
Piscataway 2
Poplar 2
Portmore 2
Porto Alegre 2
San Francisco 2
Totale 7.557
Salva come PNG Salva come JPEG
Nome #
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome 257
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 219
A Case of Plasmacytoid Variant of Bladder Cancer with a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature 209
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 208
Androgen-deprivation therapy is more than palliation in oligometastatic prostate cancer 202
Better Together: Targeted Combination Therapies in Breast Cancer 202
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials 197
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes 195
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial 190
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study 189
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer 185
Prognostic value of preoperative serum levels of periostin (PN) in early breast cancer (BCa) 185
Targeting androgen-independent pathways: new chances for patients with prostate cancer? 175
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 174
Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study 171
May adjuvant therapy play a role for the management of renal cell carcinoma? A review of literature and ongoing trials 171
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 168
Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial 168
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey 165
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients 165
Bone metastases from prostate cancer: hormonal therapy 164
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma 164
Combinations of hormonal therapy and chemotherapy 163
Cardiovascular disease (CVD) markers in patients(pts) with prostate cancer(PCa) treated with GN-RH agonists(AG) or antagonist(AN): a prospective cohort study 159
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer 155
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 153
A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer 153
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 149
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study 146
To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone 146
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience 145
Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes 142
Treatment of elderly patients with metastatic renal cell carcinoma 142
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223 142
861P Time to castration resistant prostate cancer (CRPC) and the risk of developing immune disorders 134
Insights from a long-term follow-up evaluation of early breast cancer (BC) outcomes by tumor subtype (TS) 128
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications 126
Beyond the Prognostic Value of 2-[18F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management 124
EFFICACY AND SAFETY OF SUNITINIB AND EVEROLIMUS AS FRONTLINE TREATMENT FOR NON-CC-RCC: A POOLED-ANALYSIS FROM RANDOMIZED TRIALS 124
Better Together: Immunotherapy as Future Combination Strategy for Breast Cancer 122
Baseline 18F-Fluoride PET-derived parameters predict modification of toxicity-and response-related blood biomarkers in prostate cancer patients treated with 223Ra-Dichloride: preliminary results 121
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival 120
Risks and benefits from CDK inhibitors for advanced HR+ Her 2- breast cancer 117
First line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients (MBC) presenting with de novo or recurrent disease 114
First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (NEO) adjuvant trastuzumab 113
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer 111
Real-world survival improvements in patients with newly diagnosed metastatic prostate cancer treated in the United States 107
Combination therapy in metastatic renal cell carcinoma: Back to the future? 105
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223 105
Dose calculation and tolerability of adjuvant AUC 7 carboplatin in 100 patients with stage I seminoma 103
Management of advanced endometrial cancer 102
HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature 100
Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases 100
Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives 96
Long-term results from INT-HER study: Retrospective evaluation of adjuvant trastuzumab in unselected HER2-positive breast cancer patients—Single institution experience 94
Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients 82
Cardiac Metastasis from Prostate Cancer: A Case Study Underlying the Crucial Role of the PSMA PET/CT 77
SUNITINIB IN METASTATIC RENAL CELL CARCINOMA: RESULTS OF A MONOCENTRIC EXPERIENCE 59
Role of FDG PET/CT in the prognostic stratification and response assessment of castration-resistant prostate cancer treated with radium-223 dichloride 56
Neoplasie prostatiche 53
null 40
Totale 8.651
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.053
article - articoli 27.998
book - libri 0
conference - conferenze 473
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.582
Totale 60.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022713 23 24 39 75 29 73 15 147 75 76 43 94
2022/2023778 58 82 11 77 141 128 0 64 122 5 80 10
2023/2024450 12 57 11 57 28 85 24 27 22 27 30 70
2024/20251.423 36 87 45 110 158 148 124 297 38 65 144 171
2025/20262.266 299 73 137 150 349 137 350 92 151 227 162 139
2026/2027192 192 0 0 0 0 0 0 0 0 0 0 0
Totale 8.651